The nation of Zimbabwe has rejected a major American health deal worth $367m (272 million pounds) over five years because of the United States' request for sensitive information.
This rejection became public following a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "skewed".
A government representative has since explained that the United States was seeking health data for research and commercial gain but was not willing to share the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for more talks to secure a deal agreeable to both sides so the country's critical HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a court suspended a related deal with the US following legal challenges were filed about the security of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral agreements to enhance openness and accountability.
As per reports, Sixteen African countries have so far agreed to these new health pacts, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no corresponding guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Effectively, our nation would supply the raw materials for scientific discovery without any assurance that the resulting innovations would be accessible to our citizens if a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting systems already set up through the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.
"This system is designed to guarantee that when a nation contributes its information, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as opposition to America," he added.
"We welcome ongoing dialogue with our US partners on how future co-operation might be arranged in a manner that respects the sovereignty and dignity of each country."
Health Experts Response
Medical experts said it acknowledged the government's concerns, but recommended that talks need to persist given that a large portion of the nation's HIV programmes depended on international support.
"In cases where specific concerns exist, such as those relating to data governance or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," it said.
This impasse highlights the continuing tensions between receiving vital international aid and protecting a country's data in an ever more interconnected world.